Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens

Clinical assessment of ChAdOx1 vectored vaccines against emerging pathogens

<p>Traditional vaccine development strategies are costly and time-consuming which makes them unsuitable for clinical assessment of new vaccines in the context of infectious diseases outbreaks. Platform technologies provide substantial manufacturing advantages and have the potential to signific...

Mô tả đầy đủ

Chi tiết về thư mục
Tác giả chính:	Moreira Folegatti, P
Tác giả khác:	Gilbert, S
Định dạng:	Luận văn
Ngôn ngữ:	English
Được phát hành:	2021
Những chủ đề:	Vaccine Clinical Development

Những quyển sách tương tự

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
Bằng: Adam Berg, et al.
Được phát hành: (2021-10-01)

Effect of Prior ChAdOx1 COVID-19 Immunisation on T-Cell Responses to ChAdOx1-HBV
Bằng: Charlotte Davis, et al.
Được phát hành: (2024-06-01)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Bằng: Zhang, C, et al.
Được phát hành: (2023)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
Bằng: Cheng Zhang, et al.
Được phát hành: (2023-06-01)

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
Bằng: Natalie Gabrielle Marchevsky, et al.
Được phát hành: (2022-07-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Bằng: Pedro M. Folegatti, et al.
Được phát hành: (2019-05-01)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
Bằng: Hannah R. Sharpe, et al.
Được phát hành: (2022-03-01)

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
Bằng: Rujittika Mungmunpuntipantip, et al.
Được phát hành: (2021-11-01)

Impact of Improper Storage of ChAdOx1-S (AstraZeneca) Vaccine on Its Efficacy and Safety
Bằng: Marek Mikołajczyk, et al.
Được phát hành: (2022-12-01)

Immunogenicity and Efficacy of Zika Virus Envelope Domain III in DNA, Protein, and ChAdOx1 Adenoviral-Vectored Vaccines
Bằng: César López-Camacho, et al.
Được phát hành: (2020-06-01)

Population-wide persistent hemostatic changes after vaccination with ChAdOx1-S
Bằng: Bas de Laat, et al.
Được phát hành: (2022-07-01)

ChAdOx1 vaccination, blood coagulation, and inflammation: No effect on coagulation but increased interleukin‐6
Bằng: Loes H. Willems, et al.
Được phát hành: (2021-12-01)

Effectiveness of the chAdOx1 nCoV-19 vaccine in preventing COVID-19 infection
Bằng: Tarana Sarwat, et al.
Được phát hành: (2022-01-01)

Safety and Reactogenicity of the ChAdOx1 (AZD1222) COVID-19 Vaccine in Saudi Arabia
Bằng: Salma Al Bahrani, et al.
Được phát hành: (2021-09-01)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
Bằng: Folegatti, P, et al.
Được phát hành: (2019)

A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination
Bằng: Tanie Natung, et al.
Được phát hành: (2023-01-01)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
Bằng: Simone Barocci, et al.
Được phát hành: (2022-03-01)

Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study
Bằng: Warawut Chaiwong, et al.
Được phát hành: (2022-12-01)

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
Bằng: Lea Krutzke, et al.
Được phát hành: (2022-07-01)

IgA Vasculitis Following ChAdOx1 nCoV-19 Vaccination
Bằng: Manabendra Basu, et al.
Được phát hành: (2024-01-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
Bằng: Tamara Garibashvili, et al.
Được phát hành: (2022-06-01)

Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination
Bằng: Jaeeun Yoo, et al.
Được phát hành: (2023-10-01)

Design, Immunogenicity and Preclinical Efficacy of the ChAdOx1.COVconsv12 Pan-Sarbecovirus T-Cell Vaccine
Bằng: Edmund G.-T. Wee, et al.
Được phát hành: (2024-08-01)

Vaccine‐induced immune thrombotic thrombocytopenia with ChAdOx1 nCoV‐19 is rare in Asia
Bằng: Kochawan Boonyawat, et al.
Được phát hành: (2022-01-01)

DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination
Bằng: Gerardo Casucci, et al.
Được phát hành: (2021-06-01)

ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago
Bằng: Chavin D. Gopaul, et al.
Được phát hành: (2022-03-01)

Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination – A Case Report
Bằng: Martin Koch, et al.
Được phát hành: (2021-07-01)

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity
Bằng: Larissa Henze, et al.
Được phát hành: (2023-01-01)

Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination
Bằng: Amarendra Kumar Shukla, et al.
Được phát hành: (2022-06-01)

Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination
Bằng: Wang-Huei Sheng, et al.
Được phát hành: (2022-04-01)

Association of Reactogenicity with Immunogenicity of the ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Hemodialysis
Bằng: Ting-Yun Lin, et al.
Được phát hành: (2022-08-01)

AstraZeneca ChAdOx1-S COVID-19 vaccine can be safely administered in patients with EDTA allergy
Bằng: Syed B. Ali, et al.
Được phát hành: (2022-03-01)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Bằng: Hermosilla, E, et al.
Được phát hành: (2022)

Comparative effectiveness and safety of homologous two-dose ChAdOx1 versus heterologous vaccination with ChAdOx1 and BNT162b2
Bằng: Eduardo Hermosilla, et al.
Được phát hành: (2022-03-01)

Antibody Detection in Healthcare Workers after Vaccination with Two Doses of the BNT162b2 or ChAdOx1 Vaccine
Bằng: Kyoung Ho Roh, et al.
Được phát hành: (2022-09-01)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
Bằng: Jer-Hwa Chang, et al.
Được phát hành: (2022-02-01)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
Bằng: Jinnam Kim, et al.
Được phát hành: (2023-04-01)

Adult-onset Still's disease after ChAdOx1 nCoV-19 vaccine: a possible association
Bằng: Laíssa Fiorotti Albertino, et al.
Được phát hành: (2022-11-01)

HBV001: Phase I study evaluating the safety and immunogenicity of the therapeutic vaccine ChAdOx1-HBV
Bằng: Tamsin Cargill, et al.
Được phát hành: (2023-11-01)

New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria<sup>®</sup>) Vaccine Administration
Bằng: Luca Lo Sardo, et al.
Được phát hành: (2023-02-01)